ENVISTA HOLDINGS CORP
NVSTNYSETrading Snapshot
- Day Range
- $22.98 β $23.51
- 52-Week Range
- $18.77 β $30.42
- Volume
- $2.59B
- Avg Volume
- $2.08B
- Shares Outstanding
- 162.7M
- Next Earnings
- Nov 9, 2026
Fundamentals Snapshot
- Annual Revenue
- $2.72B
- Last Q Revenue
- $731M
- P/E Ratio
- 40.2
- P/S Ratio
- 1.4x
- EPS (TTM)
- $0.59
- Dividend Yield
- 0.00%
- Dilution (1yr)
- β3.6%
Why Investors Own NVST
- βHigh-growth profile β revenue up +30.8% YoY with expanding US Equity exposure.
- βHealthy economics β 43% gross margin and 12% free-cash-flow margin.
- βNew products and segments could unlock additional revenue streams.
Execution delays, intensifying competition, and valuation compression if growth decelerates.
ENVISTA HOLDINGS CORP
NVSTAbout ENVISTA HOLDINGS CORP
Envista Holdings Corporation is an enterprise dedicated to the development and distribution of a comprehensive range of dental solutions. These offerings are crucial for the identification, therapeutic intervention, and preventative care of diverse oral health issues, specifically addressing the teeth, gingiva (gums), and their supporting bone structures. The company's principal location is in Brea, California, and it maintains a workforce comprising 12,800 full-time personnel. The firm organizes its business activities into two main divisions: "Specialty Products & Technologies" and "Equipment & Consumables." The Specialty Products & Technologies division concentrates on the creation, fabrication, and promotion of sophisticated dental implant systems, advanced prosthetic devices, and their associated digital treatment software and technological advancements. This segment also provides orthodontic remedies, including bracket systems, clear aligners, and various items for dental laboratories. Conversely, the Equipment & Consumables division is responsible for conceptualizing, producing, and bringing to market a wide array of dental apparatus and vital supplies intended for professional dental clinics. This extensive catalog includes digital imaging instruments, specialized software, and visual or magnification systems; patient treatment units and other essential fixtures for dental practices; complete endodontic kits along with their complementary consumable items; materials and tools for restorative dentistry; rotary cutting tools (burs); impression-making compounds; adhesive agents and dental cements; and products designed for infection control.
Otter Score Breakdown
How it's scoredFive components, each rated 1β5β and equally weighted (20%), averaged to a 0β100 score:π Quality β gross marginπ Growth β revenue YoYβοΈ Valuation β P/S ratioβ‘ Momentum β 30-day price changeπ§ Dilution β 1-yr share issuance (buybacks score higher)Analyst Price Target
βLatest News & Updates
New Strong Buy Stocks for September 28th
VG, HCSG, NVST, EQNR and HMN have been added to the Zacks Rank #1 (Strong Buy) List on September 28, 2026.

NVST vs. ABT: Which Stock Is the Better Value Option?
Investors with an interest in Medical - Products stocks have likely encountered both Envista (NVST) and Abbott (ABT). But which of these two companies is the best option for those looking for undervalued stocks?

Best Value Stocks to Buy for September 21st
SLDE, HHH and NVST made it to the Zacks Rank #1 (Strong Buy) value stocks list on September 21st, 2026.

Should Value Investors Buy Envista (NVST) Stock?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and

Down 12% in 4 Weeks, Here's Why You Should You Buy the Dip in Envista (NVST)
Envista (NVST) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates hi

Envista Holdings Corporation (NVST) Analyst/Investor Day Transcript
Envista Holdings Corporation (NVST) Analyst/Investor Day Transcript